Tfg Asset Management Gp LTD Celldex Therapeutics, Inc. Transaction History
Tfg Asset Management Gp LTD
- $396 Million
- Q2 2025
A detailed history of Tfg Asset Management Gp LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 316,150 shares of CLDX stock, worth $8.75 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
316,150
Previous 261,000
21.13%
Holding current value
$8.75 Million
Previous $4.74 Million
35.8%
% of portfolio
1.63%
Previous 1.37%
Shares
3 transactions
Others Institutions Holding CLDX
# of Institutions
201Shares Held
68.3MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$169 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$145 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$109 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$106 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.29B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...